REVUMENIB CITRATE
UNII YL4RYN734D

Substance Identification & Data

This profile provides standardized clinical and technical data for Revumenib Citrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YL4RYN734D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2761046-45-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
YL4RYN734D
CAS Registry Number
2761046-45-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
REVUMENIB CITRATE
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
YL4RYN734D
The specific atomic composition represented as a molecular structure string.
InChIKey
C32H47FN6O4S.C6H8O7.H2O
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
UBXFWTFPYATLBT-SGBGZXBGSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
USAN ID
LM-176
Identifier assigned by the United States Adopted Names Council.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C1[C@H](CC[C@@H](C1)CN2CCC3(CC2)CN(c4ncncc4Oc5c(C(=O)N(CC)C(C)C)cc(cc5)F)C3)NS(CC)(=O)=O.OC(CC(=O)O)(CC(=O)O)C(=O)O.O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Revumenib Citrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

REVUMENIB CITRATE

Common Names & Synonyms

REVUMENIB CITRATE [USAN]
REVUMENIB CITRATE [WHO-DD]
REVUMENIB MONOCITRATE MONOHYDRATE

Brand / Trade Names

REVUFORJ

Systematic Nomenclature

2-((4-(7-((TRANS-4-(ETHANESULFONAMIDO)CYCLOHEXYL)METHYL)-2,7-DIAZASPIRO(3.5)NONAN-2-YL)PYRIMIDIN-5-YL)OXY)-N-ETHYL-5-FLUORO-N-(PROPAN-2-YL)BENZAMIDE-2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID MONOHYDRATE
BENZAMIDE, N-ETHYL-2-((4-(7-((TRANS-4-((ETHYLSULFONYL)AMINO)CYCLOHEXYL)METHYL)-2,7-DIAZASPIRO(3.5)NON-2-YL)-5-PYRIMIDINYL)OXY)-5-FLUORO-N-(1-METHYLETHYL)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE, HYDRATE (1:1:1)

NDC Products Containing REVUMENIB CITRATE

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: